Unlearn.AI

Our Machine Learning Scientist, Daniele Bertolini, will be presenting at the upcoming @MRCTCenter webinar, “AI Digital Twins and Synthetic Data: Practical Use Cases for Clinical Research” on November 18 at 12 PM ET. This session will explore how #digitaltwins and synthetic data…

Across the industry, #clinical teams are using purpose-built #AI to make faster go/no-go calls, strengthen signals in underpowered subgroups, and model outcomes with greater confidence. Internal builds take time—and in this race, speed wins. Unlearn delivers disease-specific…

On October 28, our Co-Founder and Head of AI, Aaron Smith, will join leading experts at the CEO Roundtable on Cancer Annual Meeting in Washington, D.C. to present “Precision Trial Simulation for Oncology Trials.” This annual meeting convenes top organizations dedicated to…

#UnlearnerSpotlight 🚀 “I get to team up with smart, supportive colleagues to take on ambitious challenges. I enjoy being in an environment where bold ideas are welcomed and explored. It feels rewarding to see those ideas grow into solutions that make a real impact.”

📊 #Clinicaltrial data is rarely perfect—different formats, missing values, and inconsistencies are inevitable. Unlearn’s new blog post shares how we transform these challenges into strength by harmonizing diverse datasets, designing models that fill gaps responsibly, and…

🧠 Building on our commitment to advancing #ALS research, we were proud to contribute to the progress highlighted at #NEALS2025 with our poster presentation, “Boosting ALS Trial Power and Efficiency with Digital Twins and NfL Data.” If we missed you at the conference, connect…

🚀 On October 15, our VP of Product, Kwame Marfo, will take the stage at the 2nd Annual Clinical Trial Innovation Summit 2025, hosted by @PanAgoraPharma and @genentech, to present “Reimagining Clinical Trials with AI-Generated Digital Twins.” ➡️ Learn more and register here:…

As #AI continues to transform the #healthcare landscape, how can organizations and leaders stay ahead of the curve? Join our Data Scientist, Rachel Mak-McCully, on October 14 for the joint panel discussion, “Future-Proofing Healthcare: AI Trends, Ethics, and the Road Ahead,”…

📊 Messy, incomplete #data is the reality of past #clinicaltrials and observational studies. At Unlearn, we’ve built the infrastructure to harmonize these diverse datasets and train Digital Twin Generators that can handle noise and missingness natively. The result is trial-ready…

🚀 This quarter, we made meaningful progress toward our vision of bringing AI-powered solutions to every part of clinical development. From new collaborations to growing engagement across immunology and metabolic disease, our partners are working with us to plan smarter studies,…

If you’re attending the 2025 NEALS Annual Meeting, don’t miss our poster, “Boosting ALS Trial Power and Efficiency with Digital Twins and NfL Data,” showing how AI-generated #digitaltwins of patients increase power in Phase 2, improving the ability to detect meaningful treatment…

Empowering #biostatistics also means empowering communication. 🗣️ In our new blog post, we explain how our AI-driven #clinicaldevelopment solutions empower statisticians with shared reference points across clinical, statistical, and regulatory teams—simplifying communication,…

Attending @NEALSConsortium in Clearwater on October 7? Don’t miss our poster, “Boosting ALS Trial Power and Efficiency with Digital Twins and NfL Data.” Learn how #digitaltwins increase power and make it easier to detect meaningful treatment effects—all while staying aligned with…

On October 7, our co-founder and Chief Scientific Officer, @AnotherJonWalsh, will speak at the joint @US_FDA — @CTTI_Trials workshop, Artificial Intelligence in Drug & Biological Product Development. His session, “Navigating the Future of AI in Drug Development” (Session 4, 3:00…

Our Machine Learning Scientist, Daniele Bertolini, will be presenting at the upcoming @MRCTCenter webinar, "AI Digital Twins & Synthetic Data: Applications to Clinical Trials" on September 30 at 11:00 AM ET. The session will cover: ➡️ An introduction to digital twins and how…

🚀 Exciting news from Unlearn! We’re thrilled to welcome Dr. Robert Lenz as a Strategic Advisor. Rob is a seasoned R&D leader with more than two decades of global development experience at Amgen, Abbott, and most recently as Head of R&D at Neumora. He has overseen hundreds of…

🚀 #AI doesn’t replace #biostatistics—it amplifies it. In our new blog post, we share how our AI-driven #clinicaldevelopment solutions, including #digitaltwins of patients, empower statisticians with new ways to detect subtle treatment effects, explore responder subgroups, and…

Have you explored our open positions yet? We're hiring! Join the innovators setting the pace for #AI in #clinicaldevelopment. 🚀 bit.ly/4njnC1d

#UnlearnerSpotlight 🚀 "What excites me most is that Unlearn isn’t just building AI for the sake of it—we’ve developed scientifically rigorous solutions that fundamentally change how trials are designed. The impact is tangible: fewer patients on placebo, more on treatment, and a…

September is World Alzheimer’s Month — a time to honor the millions of people and families living with this disease, and to recognize the urgency of advancing new therapies. At Unlearn, we apply #AI to solve some of the biggest bottlenecks in #clinicaldevelopment. Learn how our…